Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue adhesion refers to the biological phenomena and molecular interactions that maintain the integrity and structure of tissues by holding cells together or anchoring them to the extracellular matrix[1][4][9]. It is mediated primarily by cell adhesion molecules, such as cadherins, integrins, selectins, and immunoglobulin superfamily members, as well as ECM proteins like collagen and laminin[3][9]. These mechanisms are essential for organizing tissues during development, maintaining tissue architecture, enabling cell signaling, and regulating processes such as morphogenesis and wound healing. Abnormalities in the molecules mediating tissue adhesion are linked to diseases such as cancer, inflammation, and fibrosis. Note: "Tissue adhesion" is a general process and not a single, actionable molecular target or receptor. For a therapeutic or research target, focus should be on specific molecules (for example, "E-cadherin" or "Integrin beta-1").
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue adhesion.